Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S0140-6736(14)62221-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Transforming Cardiovascular Care With Artificial Intelligence: From Discovery to Practice: JACC State-of-the-Art Review.
J Am Coll Cardiol
July 2024
Molecular Medicine, Scripps Research Translational Institute, Scripps Research, La Jolla, California, USA.
Article Synopsis
- AI is revolutionizing cardiovascular care and research by introducing advanced diagnostic tools, digital biomarkers, and quality evaluation systems.
- These innovations aim to increase access to cardiovascular screening and monitoring, particularly for underserved populations lacking specialized care.
- The review discusses the potential for personalized and effective treatments through AI advancements while emphasizing the necessary precautions and strategies to ensure successful implementation in healthcare.
Comparative study of imaging and pathology of primary mucinous adenocarcinoma with different imaging manifestations.
Clin Respir J
April 2024
Department of Respiratory and Critical Care, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Background: Pulmonary mucinous adenocarcinoma is a special type of lung cancer. Its imaging manifestations are diverse, which brings challenges to clinical diagnosis. However, its formation mechanism is unclear.
View Article and Find Full Text PDFMachine Learning Approaches to Investigate the Structure-Activity Relationship of Angiotensin-Converting Enzyme Inhibitors.
ACS Omega
November 2023
Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok 10700, Thailand.
Angiotensin-converting enzyme inhibitors (ACEIs) play a crucial role in treating conditions such as hypertension, heart failure, and kidney diseases. Nevertheless, the ACEIs currently available on the market are linked to a variety of adverse effects including renal insufficiency, which restricts their usage. There is thus an urgent need to optimize the currently available ACEIs.
View Article and Find Full Text PDFEvaluation of Hydrangea Cultivars for Tolerance Against Root Rot Caused by .
Plant Dis
December 2023
Department of Agriculture and Environmental Sciences, Otis L. Floyd Nursery Research Center, College of Agriculture, Tennessee State University, McMinnville, TN.
Root rot caused by Schltdl. is a newly identified disease in oakleaf hydrangea. Some cultivars such as Pee Wee and Queen of Hearts grown in pot-in-pot container systems showed root rot symptoms after late spring frost in May 2018 with 40 and 60% incidence in the infected nursery, respectively.
View Article and Find Full Text PDFAngiotensin Receptor Neprilysin Inhibitor Use and Blood Pressure Lowering in Patients With Heart Failure With Reduced Ejection Fraction Across the Spectrum of Kidney Function: An Analysis of the Veterans Administrative Health System.
J Card Fail
March 2023
Nephrology Division, Internal Medicine Department, Loma Linda University School of Medicine & Loma Linda University Health, Loma Linda, CA; Nephrology Division, Internal Medicine Department, Loma Linda VA Healthcare System, Loma Linda, CA.. Electronic address:
Background: A substantial proportion of patients with heart failure and kidney disease have poorly controlled blood pressures. This study aimed to evaluate patterns of blood pressure after initiation of an angiotensin receptor neprilysin inhibitor (ARNI) or an angiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB) across the spectrum of kidney function.
Methods: Between 2016 and 2020, we evaluated 26,091 patients admitted to a Veterans Affairs hospital for an acute heart failure exacerbation with reduced ejection fraction.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!